awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41418657-5684BE81-6849-4844-A1A6-5FEDEE044E84
Q41418657-5684BE81-6849-4844-A1A6-5FEDEE044E84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418657-5684BE81-6849-4844-A1A6-5FEDEE044E84
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study.
P2860
Q41418657-5684BE81-6849-4844-A1A6-5FEDEE044E84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418657-5684BE81-6849-4844-A1A6-5FEDEE044E84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4be565ce433d67233099044320d93ab64be3f37
P2860
Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.